Share of the population living with HIV receiving antiretroviral therapy in Estonia
Estonia: Share of the population living with HIV receiving antiretroviral therapy was 68.6% in 2022. ◆ Volatile
Share of the population living with HIV receiving antiretroviral therapy in Estonia, 2000–2022
Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in %.
Analysis
Estonia recorded 68.6% for share of the population living with hiv receiving antiretroviral therapy in 2022.
That represents a change of down 2.1% on the previous year and up 52.2% over ten years.
Over the whole period, share of the population living with hiv receiving antiretroviral therapy in Estonia peaked at 72.4% in 2019 and was at its lowest, 2.0%, in 2003.
That places Estonia 82nd out of 149 countries with data for 2022, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 10.2% | 2.0% | 25.8% | 10 |
| 2010s | 55.4% | 33.8% | 72.4% | 10 |
| 2020s | 69.8% | 68.6% | 70.6% | 3 |
Countries ranked near Estonia
More reference data data for Estonia
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 0.0827 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 0.0328 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 0.2652 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 0.0363 (2050)
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 0.2652 (2050)
- Emission Totals - Emissions (N2O) - Manure applied to Soils 0.2774 (2050)
- Emission Totals - Emissions (N2O) - Manure Management 0.193 (2050)
- Emission Totals - Emissions (N2O) - Manure left on Pasture 0.1743 (2050)
- Emission Totals - Emissions (N2O) - IPCC Agriculture 1.31 (2050)
- Emission Totals - Emissions (N2O) - Crop Residues 0.1975 (2050)
Frequently asked questions
- What is share of the population living with hiv receiving antiretroviral therapy in Estonia?
- Share of the population living with hiv receiving antiretroviral therapy in Estonia was 68.6% in 2022, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
- What is the highest share of the population living with hiv receiving antiretroviral therapy recorded in Estonia?
- The highest recorded value was 72.4% in 2019.
- What is the lowest share of the population living with hiv receiving antiretroviral therapy recorded in Estonia?
- The lowest recorded value was 2.0% in 2003.
- How does Estonia rank for share of the population living with hiv receiving antiretroviral therapy?
- Estonia ranks 82nd out of 149 countries with data for 2022.
- Is share of the population living with hiv receiving antiretroviral therapy rising or falling in Estonia?
- Over the last ten years it is up 52.2%. The long-run trend across the full record is volatile.
- Where does this Estonia data come from?
- The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of Share of the population living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.